Third Rock Closes Fourth Biotech Venture Fund At $616M
Third Rock Ventures LLC said Monday it has raised $616 million in an oversubscribed fourth fund that like its predecessors invests in new health care companies with a focus on oncology,...To view the full article, register now.
Already a subscriber? Click here to view full article